Trending...
- Regcrest LLC Publishes Free 50-State Tax Account Closure Checklist Tool
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
CARTHAGE, Mo. - PennZone -- Stratum Nutrition®, (a business of ESM Technologies), and Adare Biome™, (a division of Adare Pharma Solutions) are pleased to announce LBiome™ has been awarded the NIE 2021 Award for their Condition Specific Category. LBiome is a human strain-derived, heat-treated postbiotic (Lactobacillus LB) that has been used as a digestive aid for over a century. NIE presented this award to LBiome for its great appeal to formulators, its vast research portfolio, shelf and gastric stability, and its versatility in dosing formats.
By definition of the International Scientific Association for Probiotics and Prebiotics (ISAPP), LBiome meets all criteria as a true postbiotic, meaning it contains the cells or cells components from the microbial source, in addition to all metabolites produced during fermentation. More than 40 published studies have been conducted on LBiome. These include clinical trials in adults and children demonstrating its extraordinary safety and benefits throughout the digestive tract. In vitro and in vivo studies have further expanded this knowledge, revealing that the cells, cell fragments, and metabolites help create an enhanced environment for the gut microbiome and strengthen the intestinal lining by providing beneficial support for a healthy brush border and tight junctions. *
More on The PennZone
Ludger Roedder, President of Adare Biome, said, "On behalf of the Adare Biome team, I am honored that LBiome has been recognized as an effective, safe, and natural ingredient to improve human nutrition. We believe in the power of postbiotics to revolutionize human health, and LBiome has proven to be a pioneer in the postbiotics space. I am convinced that LBiome is well-positioned to meet growing interest and consumer needs to improve human health and wellbeing by using postbiotics."
LBiome has more digestive health-supporting research than any other human origin postbiotic currently on the market. In addition, many of the LBiome clinicals show safety and digestive health support in pediatrics, which is not seen in many postbiotic competitors.
Micah Osborne, President of Stratum Nutrition, said, "As a proud distributor of LBiome, we are excited to see it gain recognition in the industry as the pioneer of postbiotics. With its proven safety and the extent of published research supporting its benefits as a digestive aid, it is the perfect addition to our ingredient portfolio. LBiome is well-positioned to meet the demand of this emerging category in the microbiome space."
More on The PennZone
For more information about Stratum Nutrition and its branded ingredients, please email Info@StratumNutrition.com or visit their website, https://www.stratumnutrition.com/.
###
About Stratum Nutrition
Stratum Nutrition®, a business of ESM Technologies, LLC, is a trusted ingredient innovator supplying unique, world-class nutrition ingredients and delivery technologies to product formulators for human and pet health. Stratum offers a portfolio of research-supported ingredients that stand out in their respective health categories as being progressive, safe, and effective, including NEM® brand eggshell membrane, LBiome™ Lactobacillus LB postbiotic, Ahiflower®, BLIS K12™, BLIS M18™, Nataxtin™ astaxanthin, Curcumin 95, and ESC® brand eggshell calcium. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.
*These statements have not been evaluated by the U.S. Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
By definition of the International Scientific Association for Probiotics and Prebiotics (ISAPP), LBiome meets all criteria as a true postbiotic, meaning it contains the cells or cells components from the microbial source, in addition to all metabolites produced during fermentation. More than 40 published studies have been conducted on LBiome. These include clinical trials in adults and children demonstrating its extraordinary safety and benefits throughout the digestive tract. In vitro and in vivo studies have further expanded this knowledge, revealing that the cells, cell fragments, and metabolites help create an enhanced environment for the gut microbiome and strengthen the intestinal lining by providing beneficial support for a healthy brush border and tight junctions. *
More on The PennZone
- Fashion vs. Fascism - Because Democracy Should Always Be In Style
- Lee Gunn IV Shares Lessons From 40 Years in the Courtroom on PodNumbra Podcast
- [New Book] "Historic Maps of Philadelphia" Available Now!
- Michael H. Kaplan Recognized for 17 Years on PHPA Workers' Compensation Panel and Advocacy for Professional Athletes
- International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
Ludger Roedder, President of Adare Biome, said, "On behalf of the Adare Biome team, I am honored that LBiome has been recognized as an effective, safe, and natural ingredient to improve human nutrition. We believe in the power of postbiotics to revolutionize human health, and LBiome has proven to be a pioneer in the postbiotics space. I am convinced that LBiome is well-positioned to meet growing interest and consumer needs to improve human health and wellbeing by using postbiotics."
LBiome has more digestive health-supporting research than any other human origin postbiotic currently on the market. In addition, many of the LBiome clinicals show safety and digestive health support in pediatrics, which is not seen in many postbiotic competitors.
Micah Osborne, President of Stratum Nutrition, said, "As a proud distributor of LBiome, we are excited to see it gain recognition in the industry as the pioneer of postbiotics. With its proven safety and the extent of published research supporting its benefits as a digestive aid, it is the perfect addition to our ingredient portfolio. LBiome is well-positioned to meet the demand of this emerging category in the microbiome space."
More on The PennZone
- Boston Industrial Solutions Introduces Personalized Printing Training
- Century Fasteners de Mexico Exhibiting at the 2026 Automotive & Aerospace Nearshoring Summit
- Retell AI White Label Platform for Agencies Launched by VoiceAIWrapper, With Branded Client Portals and No Per-Minute Markup
- FOCUS Names Mark Phillips Senior Vice President of Business Development
- Notaron Expands Online Notarization Access Following Wisconsin Approval
For more information about Stratum Nutrition and its branded ingredients, please email Info@StratumNutrition.com or visit their website, https://www.stratumnutrition.com/.
###
About Stratum Nutrition
Stratum Nutrition®, a business of ESM Technologies, LLC, is a trusted ingredient innovator supplying unique, world-class nutrition ingredients and delivery technologies to product formulators for human and pet health. Stratum offers a portfolio of research-supported ingredients that stand out in their respective health categories as being progressive, safe, and effective, including NEM® brand eggshell membrane, LBiome™ Lactobacillus LB postbiotic, Ahiflower®, BLIS K12™, BLIS M18™, Nataxtin™ astaxanthin, Curcumin 95, and ESC® brand eggshell calcium. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.
*These statements have not been evaluated by the U.S. Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Source: Stratum Nutrition
0 Comments
Latest on The PennZone
- Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
- Ten Ten Ten Awards Provisional Certification to Cara AI for Home-Based Health Assessments
- IDI Consulting Partners with the American Heart Association to Advance Heart Health Awareness
- Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
- Bethany Nikitenko Appointed to Philadelphia Trial Lawyers Association Diversity Committee
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
- The Culture and Travel Report Enters a New Chapter as Travel and Hospitality Brands Take Notice
- Regcrest LLC Publishes Free 50-State Tax Account Closure Checklist Tool
- HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
- P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
- DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
- French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
- LET US READ Documentary on Dyslexia and Literacy to Screen at TCL Chinese 6 in Hollywood
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
- STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
